Publication & Citation Trends
Publications
0 total
Multiple Myeloma Treatment in Real‐world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study OA
Cited by 70
Semantic Scholar
Title Page / Contents / Imprint / Guidelines for Authors
Cited by 0
Semantic Scholar
Bortezomib-Containing Regimens Are Effective in Multiple Myeloma - Results of a Non-Interventional Phase IV Study
Cited by 7
Semantic Scholar
of the NHL-B2 trial of the DSHNHL the Treatment of Elderly Patients with Aggressive Lymphomas: Results 2-weekly or 3-weekly CHOP Chemotherapy with or without Etoposide for
Cited by 0
Semantic Scholar
Formation, and Tumorigenicity CD44 Regulates Hematopoietic Progenitor Distribution, Granuloma
Cited by 0
Semantic Scholar
Simvastatin does not prevent acute cardiac allograft rejection in CD28-deficient mice
Cited by 3
Semantic Scholar
Rituximab Overcomes Sex as a Strong Adverse Prognostic Factor for Treatment Outcome in Patients with Follicular Lymphoma: Analysis of Patients Treated with Rituximab/CHOP or CHOP in Randomized Trials of the German Low Grade Lymphoma Study Group (GLSG).
Cited by 7
Semantic Scholar
Prognostic factors for hematotoxicity of chemotherapy in aggressive non-Hodgkin's lymphoma. OA
Cited by 42
Semantic Scholar
aggressive lymphomas: results of the NHL-B1 trial of the DSHNHL for the treatment of young patients with good-prognosis (normal LDH) Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide
Cited by 0
Semantic Scholar
Autologous Stem Cell Transplantation after Myeloablative Therapy in First Remission May Be Beneficial in Patients with Advanced Stage Follicular Lymphoma after Front-Line Therapy with R-CHOP. An Analysis of Two Consecutive Studies of the German Low Grade Lymphoma Study Group (GLSG)
Cited by 11
Semantic Scholar
Research Topics
Lymphoma Diagnosis and Treatment
(28)
Immunotherapy and Immune Responses
(15)
Chronic Lymphocytic Leukemia Research
(12)
Immune Cell Function and Interaction
(11)
T-cell and B-cell Immunology
(10)
Affiliations
Ontario Institute for Cancer Research
Centre National de la Recherche Scientifique
University of Cologne
University of Toronto
University of Münster